HELYX INDUSTRIES
Research HELYX INDUSTRIES (HLX.MI) on Bullrun: market cap EUR 19.57M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHLX.MI
- ExchangeEXGM
- CountryItaly
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 19.57M
- Financial periodFY2025
- RevenueEUR 2.09M
- Revenue growth99.0%
- Net income-EUR 4.38M
- Free cash flow-EUR 1.89M
- Gross margin64.4%
Valuation Snapshot
latest market cap is EUR 19.57M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 2.09M | -EUR 4.38M | -EUR 1.89M | 64.4% | n/a | EUR 1.26M | EUR 1.12M | EUR 20.16M |
| FY2024 | EUR 1.05M | -EUR 5.94M | -EUR 3.59M | 48.2% | -0.06 | EUR 1.50M | EUR 333.89K | EUR 23.67M |
| FY2023 | EUR 118.05K | -EUR 2.47M | -EUR 1.48M | -167.1% | -0.22 | EUR 2.31M | EUR 496.78K | EUR 29.67M |
| FY2022 | EUR 145.68K | -EUR 1.31M | -EUR 1.20M | -124.8% | -0.16 | EUR 3.79M | n/a | EUR 5.95M |
| FY2021 | n/a | n/a | n/a | n/a | -0.07 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 19.57M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About HELYX INDUSTRIES
Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets invitro diagnostic medical devices in Italy. The company through its Sagitta, a proprietary reagent platform designed to support deep multiplexing qPCR; and stable multiplex reagents. It also offers HYRIS bAPP, a software interface for managing and instructing Hyris system operations, as well as HYRIS bCUBE, an IVDR device compliant, designed according to industrial quality and operational safety criteria;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HELYX INDUSTRIES's market cap?
HELYX INDUSTRIES's market capitalization is EUR 19.57M.
What does HELYX INDUSTRIES do?
Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets invitro diagnostic medical devices in Italy. The company through its Sagitta, a proprietary reagent platform designed to support deep multiplexing qPCR; and stable multiplex reagents. It also offers HYRIS bAPP, a software interface for managing and instructing Hyris system operations, as well as HYRIS bCUBE, an IVDR device compliant, designed according to industrial quality and operational safety criteria; and HYRIS bGATE, a gateway device that allows laboratories to integrate data and results.